This clinical study is the first to explore the role of EstroG-100®, a plant-based formulation, in managing menopausal symptoms and improving quality of life. Conducted as a prospective, single-arm interventional study, it evaluates the effects of supplementation over a 12-week period in postmenopausal women. The research focuses on assessing changes in climacteric symptoms using standardized menopause rating and treatment satisfaction scales.